TAŞ, F. Et Al. 2014. Clinical significance of serum M30 and M65 levels in patients with breast cancer. BIOMEDICINE & PHARMACOTHERAPY , vol.68, no.8 , 1135-1140.

TAŞ, F., KARABULUT, S., YILDIZ, İ., & DURANYILDIZ, H. D., (2014). Clinical significance of serum M30 and M65 levels in patients with breast cancer. BIOMEDICINE & PHARMACOTHERAPY , vol.68, no.8, 1135-1140.

TAŞ, Faruk Et Al. "Clinical significance of serum M30 and M65 levels in patients with breast cancer," BIOMEDICINE & PHARMACOTHERAPY , vol.68, no.8, 1135-1140, 2014

TAŞ, Faruk Et Al. "Clinical significance of serum M30 and M65 levels in patients with breast cancer." BIOMEDICINE & PHARMACOTHERAPY , vol.68, no.8, pp.1135-1140, 2014

TAŞ, F. Et Al. (2014) . "Clinical significance of serum M30 and M65 levels in patients with breast cancer." BIOMEDICINE & PHARMACOTHERAPY , vol.68, no.8, pp.1135-1140.

@article{article, author={Faruk TAŞ Et Al. }, title={Clinical significance of serum M30 and M65 levels in patients with breast cancer}, journal={BIOMEDICINE & PHARMACOTHERAPY}, year=2014, pages={1135-1140} }